Stocks›Healthcare
WatchAlert

Jenburkt Pharmaceuticals Limited

JENBURPH · BSE · Healthcare · As of 8 Nov 2026
₹974.00
+₹33.05 (+3.51%)(1D)
₹845.0052 Week Range₹1,317.00
Market Cap
₹465.56 Cr
P/E (Sector)
12.4 (32.3)
P/B Ratio
—
Dividend Yield
1.71%
ROE
7.9%
Debt / Equity
—
Anvest Score
38/100
  • Valuation
    34
  • Quality
    20
  • Growth
    68
  • Health
    —
  • Momentum
    33
Loading company profile…

Fundamentals

P/E Ratio (TTM)
12.37
Sector median P/E
32.29
P/B Ratio
—
Sector median P/B
4.4
EPS (TTM)
₹78.71
Market Cap
₹465.56 Cr
Dividend Yield
1.71%
ROE
7.88%
ROCE
1.91%
Profit Margin
19.4%
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Jenburkt Pharmaceuticals Limited FAQs

3 topics
Expand
What does the Jenburkt Pharmaceuticals Limited (JENBURPH) stock page cover?
Jenburkt Pharmaceuticals Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for JENBURPH?
Jenburkt Pharmaceuticals Limited is currently shown with a delayed price near ₹974, P/E 12.37, and ROE 7.88%.
Does the JENBURPH page provide investment advice?
No. The JENBURPH page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights